The document discusses several disorders of the heart and lungs, including:
- Coronary artery disease, which involves a reduction of blood flow to the heart muscle due to plaque buildup in the heart's arteries.
- Cardiomyopathy, which affects the heart muscle and increases the risk of irregular heartbeats and sudden cardiac death.
- Hypertensive heart disease, which includes complications of high blood pressure that affect the heart.
- Heart failure, which occurs when the heart is unable to pump sufficiently to meet the body's needs.
Epidemiology , diagnosis and treatment of Hypertension Toufiqur Rahman
Hypertension, Blood pressure, Systolic Hypertension, Diastolic Hypertension, Epidemiology, Classification of hypertention, Type of hypertension, aetiology of hypertension, Clinical features, complications of hypertension, ambulatory blood pressure monitoring, Resistant hypertension, anti hypertensives,
Heart Failure (Dr Vosik Presentation) Symposia presented in Milot, Haiti at Hôpital Sacré Coeur.
CRUDEM’s Education Committee (a subcommittee of the Board of Directors) sponsors one-week medical symposia on specific medical topics, i.e. diabetes, infectious disease. The classes are held at Hôpital Sacré Coeur and doctors and nurses come from all over Haiti to attend.
Epidemiology , diagnosis and treatment of Hypertension Toufiqur Rahman
Hypertension, Blood pressure, Systolic Hypertension, Diastolic Hypertension, Epidemiology, Classification of hypertention, Type of hypertension, aetiology of hypertension, Clinical features, complications of hypertension, ambulatory blood pressure monitoring, Resistant hypertension, anti hypertensives,
Heart Failure (Dr Vosik Presentation) Symposia presented in Milot, Haiti at Hôpital Sacré Coeur.
CRUDEM’s Education Committee (a subcommittee of the Board of Directors) sponsors one-week medical symposia on specific medical topics, i.e. diabetes, infectious disease. The classes are held at Hôpital Sacré Coeur and doctors and nurses come from all over Haiti to attend.
The Advanced Cardiovascular Life Support (ACLS) algorithm is a systematic, evidence-based approach designed to guide healthcare providers in the urgent treatment of: Cardiac arrest. Arrhythmias. Stroke. Other life-threatening cardiovascular emergencies.
Cardiac myopathy is a heart-related disorder. many types are there in cardiomyopathy .4 types of CMP is hypertrophic CMP, dilated CMP, restrictive CMP, stress CMP. causes of this are node related problem,ischemic condion of the heart .symptoms to this is chest pain breathlessness, edema like cardiacfailure will happen at last . manage mesvn t like betablockers , ace inhibitors doamine .dobutamine, and diuretics should be given to the patient .surgical manage meant is septal ablation, and heart transplantation should be given to the patient
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
3. Introduction:
In humans, the heart is located between the lungs, in the middle
compartment of the chest.
the heart is divided into four chambers: upper left and right atria and lower
left and right ventricles.
The heart is enclosed in a protective sac, the pericardium, which also
contains a small amount of fluid. The wall of the heart is made up of three
layers: epicardium, myocardium, and endocardium.
The heart beats at a resting rate close to 72 beats per minute.
Cardiovascular diseases (CVD):
The most common cause of death globally as of 2008, accounting for 30%
of deaths. Of these more than three quarters are a result of coronary artery
disease and stroke.
Risk factors include: smoking, being overweight, little exercise, high
cholesterol, high blood pressure, and poorly controlled diabetes, among
others. Cardiovascular diseases frequently do not have symptoms or may
cause chest pain or shortness of breath.
Diagnosis of heart disease is often done by the taking of a medical
history, listening to the heart-sounds with a stethoscope, ECG,
and ultrasound. Specialists who focus on diseases of the heart are
called cardiologists, although many specialties of medicine may be involved
in treatment.
8. Coronary artery disease (CAD): also known as ischemic heart
disease (IHD), involves the reduction of blood flow to the heart muscle due to build-
up of plaque in the arteries of the heart. It is the most common of the cardiovascular
diseases .Types include stable angina, unstable angina, myocardial infarction,
and sudden cardiac death.
Signs and symptoms:
Chest pain that occurs regularly with activity, after eating, or at other predictable times is
termed stable angina and is associated with narrowing's of the arteries of the heart.
Angina that changes in intensity, character or frequency is termed unstable. Unstable
angina may precede myocardial infarction. In adults who go to the emergency department
with an unclear cause of pain, about 30% have pain due to coronary artery disease
Diagnosis:
Baseline electrocardiography(ECG).
Exercise ECG – Stress test.
Exercise radioisotope test (nuclear stress test, myocardial scintigraphy.
Echocardiography (including stress echocardiography).
Coronary angiography.
Intravascular ultrasound.
Magnetic resonance imaging (MRI).
Treatment:
Medical treatment – drugs (e.g., cholesterol
lowering medications, beta-blockers,
nitro-glycerine,
calcium channel blockers, etc.)
Coronary artery bypass grafting (CABG)
9. Cardiomyopathy:
It is a group of diseases that affect the heart muscle. An irregular heart
beat and fainting may occur. Those affected are at an increased risk of sudden
cardiac death. Cardiomyopathies are divided into 3 main types Dilated ,
Hypertrophic , Restrictive.
Signs and symptoms:
Symptoms of cardiomyopathies may include fatigue, swelling of the lower
extremities and shortness of breath. Further indications of the condition may include:
arrhythmia, fainting, and dizziness.
10. Diagnosis:
Among the diagnostic procedures done to determine a cardiomyopathy are:
Physical exam.
Family history.
Blood test.
ECG.
Echocardiogram.
Stress test.
Genetic testing.
Treatment:
55555555555555555555555555555555
55557789632188885556666666
Dilated :
Diuretics, ACE inhibitors,
angiotensin II receptor
blockers, beta-
blockers, spironolactone or e
plerenone, digoxin, ICD,
cardiac resynchronization
therapy, anticoagulants
Hypertrophic:
Beta-
blockers ± verapamil ±disopy
ramide ± septal
myotomy ±catheter alcohol
ablation
Restrictive:
Phlebotomy for
hemochromatosis
Endocardia resection
Hydroxyurea for hyper
eosinophilia
11. Hypertensive heart disease:
It includes a number of complications of high blood pressure that affect the heart.
While there are several definitions of hypertensive heart disease in the medical
literature, the term is most widely used in the context of the International
Classification of Diseases (ICD) coding categories.
12. Signs and symptoms:
Fatigue, Irregular pulse or palpitations, Swelling of feet and ankles,
Weight gain, Nausea, Shortness of breath.
Diagnosis:
Urinalysis and urinary albumin: creatinine ratio; if abnormal, consider renal
ultrasonography.
Blood tests: Fasting lipids, creatinine , potassium.
Renal ultrasonography if Creatinie increased.
Evaluate for aldosteronism if potassium decreased.
ECG: If left ventricular hypertrophy, consider echocardiography.
Sometimes thyroid-stimulating hormone measurement.
Evaluate for pheochromocytoma or a sleep disorder if BP elevation sudden and labile or
severe.
Treatment:
Treatment involves lifestyle changes and drugs, including diuretics, beta-
blockers, ACE inhibitors, angiotensin II receptor blockers, and calcium
channel blockers.
14. Cardiac arrest is the cessation of cardiac mechanical activity resulting in the
absence of circulating blood flow. Cardiac arrest stops blood from flowing to
vital organs, depriving them of oxygen, and, if left untreated, results in death.
Symptoms and Signs
In critically or terminally ill patients, cardiac arrest is often preceded by a
period of clinical deterioration with rapid, shallow breathing, arterial
hypotension, and a progressive decrease in mental alertness. In sudden cardiac
arrest, collapse occurs without warning, occasionally accompanied by a brief
(< 5 sec) seizure.
Diagnosis
Clinical evaluation.
Cardiac monitor and ECG.
Sometimes testing for cause (eg, echocardiography, chest x-ray, or chest
ultrasonography).
Treatment
CPR.
When possible, treatment of primary cause.
Post resuscitative care.
If response to IV fluid is inadequate, most clinicians give one or more
vasopressor drugs (eg, norepinephrine, epinephrine, dopamine, vasopressin).
15. Heart failure:
It is also known as congestive heart failure (CHF), is when the heart is unable to pump
sufficiently to blood flow to meet the body's needs.
Signs and symptoms:
Heart failure symptoms are traditionally and somewhat arbitrarily divided into
"left" and "right" sided, recognizing that the left and right ventricles of the heart
supply different portions of the circulation. However, heart failure is not
exclusively backward failure (in the part of the circulation which drains to the
ventricle).
Diagnosis:
Ultrasound, Chest X-ray, Electrophysiology, Blood tests, Angiography.
Drug treatment:
Drug treatment of heart failure involves-
Symptom relief: Diuretics, nitrates, or
digoxin.
Long-term management and improved
survival: ACE inhibitors, beta-blockers,
aldosterone antagonists, angiotensin II
receptor blockers (ARBs), or angiotensin
receptor/neprilysin inhibitors (ARNIs)
16. Pulmonary heart disease:
it is also known as cor pulmonale, is the enlargement and failure of the right
ventricle of the heart as a response to increased vascular resistance (such as
from pulmonic stenosis) or high blood pressure in the lungs.
Signs and symptoms:
Shortness of breath, Wheezing,
Cyanosis,
Ascites, Jaundice, Enlargement of
the liver,
Raised jugular venous pressure.
Diagnosis:
Chest x-ray ,ECG, Thrombophilia screen.
Treatment:
antibiotics, expectorants, oxygen therapy, diuretics, digitalis, vasodilators,
and anticoagulants.
17. Heart arrhythmia:
it is(also known as arrhythmia, dysrhythmia or irregular heartbeat) is a group
of conditions in which the heartbeat is irregular, too fast or too slow. A heart rate
that is too fast – above 100 beats per minute in adults – is called tachycardia, and a
heart rate that is too slow – below 60 beats per minute – is called bradycardia.
Signs and symptoms:
if an arrhythmia results in a heartbeat that is too fast, too slow or too weak to
supply the body's needs, this manifests as a lower blood pressure and may
cause light-headedness or dizziness, or syncope (fainting).
Some types of arrhythmia result in cardiac arrest, or sudden death.
Diagnosis of arrhythmia:
blood and urine tests.
ECG (electrocardiogram).
Holtermonitor - a wearable device that records the heart for 1-2 days.
Echocardiogram.
chest X-ray.
electrophysiological testing (or EP studies).
heart catheterization.
18. Myocarditis:
Myocarditis, also known as inflammatory cardiomyopathy, is inflammation of the heart
muscle. Symptoms can include shortness of breath, chest pain, decreased ability to
exercise, and an irregular heartbeat. The duration of problems can vary from hours to
months. Complications may include heart failure due to dilated cardiomyopathy or cardiac
arrest.
Diagnosis:
Electrocardiogram (ECG), Chest X-ray, MRI, Echocardiogram, Blood tests, Cardiac
catheterization and end myocardial biopsy.
Treatment:
Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers
(ARBs), Beta blockers, Diuretics.
20. Signs and symptoms:
• Some children have no signs while others may exhibit shortness of
breath, cyanosis, fainting, heart murmur, under-development of limbs
and muscles, poor feeding or growth, or respiratory infections.
Diagnosis:
• Many congenital heart defects can be diagnosed prenatally by foetal
echocardiography. It can be an abdominal ultrasound or transvaginal
ultrasound.
Treatment:
• CHD may require surgery and medications.
• Medications include diuretics, which aid the body in eliminating water,
salts, and digoxin for strengthening the contraction of the heart.
• This slows the heartbeat and removes some fluid from tissues.
• Some defects require surgical procedures to restore circulation back to
normal and in some cases, multiple surgeries are needed.
25. Asthma
• Coughing, wheezing, and shortness of breath that occur in response to specific
triggers are the most common symptoms.
Doctors confirm the diagnosis of asthma by doing breathing (pulmonary
function) tests.
Asthma is a condition in which your airways narrow and swell and
produce extra mucus. This can make breathing difficult and trigger
coughing, wheezing and shortness of breath.
26. For some people, asthma signs and symptoms flare up in certain situations:
• Exercise-induced asthma, which may be worse when the air is cold and dry
• Occupational asthma, triggered by workplace irritants such as chemical fumes,
gases or dust.
• Allergy-induced asthma, triggered by airborne substances, such as pollen, mild
spores, cockroach waste or particles of skin and dried saliva shed by pets (pet
dander).
CLASSIFICATION OF DRUGS:
I. Bronchodilators:
A. β 2 Sympathomimetic: Salbutamol, Terbutaline, Bambuterol, Salmeterol,
Formoterol, Ephedrine.
B. Methylxanthines: Theophylline (anhydrous), Aminophylline, Choline
theophylline, Hydroxyethyl theophylline, Theophylline ethanol ate of
piperazine, Doxophylline.
C. Anticholinergic : Ipratropium bromide, Tiotropium bromide.
II. Leukotriene antagonists: Montelukast, Zafirlukast.
III. Mast cell stabilizers: Sodium cromoglycate, Ketotifen.
27. IV. Corticosteroids:
A. Systemic: Hydrocortisone, Prednisolone and others.
B. Inhalational: Beclomethasone dipropionate, Budesonide, Fluticasone
propionate, Flunisolide, Ciclesonide.
V. Anti- IgE antibody : Omalizumab.
28. COPD:
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung
disease that causes obstructed airflow from the lungs. Symptoms include breathing
difficulty, cough, mucus (sputum) production and wheezing. It's caused by long-
term exposure to irritating gases or particulate matter, most often from cigarette
smoke. People with COP Dare at increased risk of developing heart disease, lung
cancer and a variety of other conditions.
Symptoms:
Shortness of breath, especially during physical activities.
Wheezing.
Chest tightness.
Having to clear your throat first thing in the morning, due to excess
mucus in your lungs.
A chronic cough that may produce mucus (sputum) that may be
clear, white, yellow or greenish.
Blueness of the lips or fingernail beds (cyanosis).
Frequent respiratory infections.
29.
30. Diagnosis:
Lung (pulmonary) function tests.
Chest X-ray.
CT scan.
Arterial blood gas analysis.
Laboratory tests.
Treatment:
Medications
Doctors use several kinds of medications to treat the symptoms and
complications of COPD. You may take some medications on a regular basis
and others as needed.
Bronchodilators: albuterol (ProAir HFA, Ventolin HFA, others), levalbuterol
(Xopenex HFA), and ipratropium (Atrovent). The long-acting bronchodilators
include tiotropium (Spiriva), salmeterol (Serevent), formoterol (Foradil,
Perforomist), arformoterol (Brovana), indacaterol (Arcapta) and aclidinium
(Tudorza).
Inhaled steroids: Fluticasone (Flovent HFA, Flonase, others) and
budesonide (Pulmicort Flex haler, Uceris, others) are examples of inhaled
steroids.
31. Combination inhalers
Some medications combine bronchodilators and inhaled steroids. Salmeterol and
fluticasone (Advair) and formoterol and budesonide (Symbicort) are examples of
combination inhalers.
Oral steroids
For people who have a moderate or severe acute exacerbation, short courses (for
example, five days) of oral corticosteroids prevent further worsening of COPD.
However, long-term use of these medications can have serious side effects, such
as weight gain, diabetes, osteoporosis, cataracts and an increased risk of
infection.
32. Lung cancer
Symptoms and Signs:
Symptoms and signs can result from local tumour progression, regional spread, or
distant metastases. Para neoplastic syndromes and constitutional symptoms may
occur at any stage of the disease.
Metastases eventually cause symptoms that vary by location. Metastases can
spread to the.
Liver, causing pain, nausea, early satiety, and ultimately hepatic
insufficiency.
Brain, causing behavioural changes, confusion, aphasia, seizures, paresis or
paralysis, nausea and vomiting, and ultimately coma and death.
Bones, causing severe pain and pathologic fractures.
Adrenal glands, rarely causing adrenal insufficiency.
33.
34. Classification
Lung cancer is classified into 2 major categories:
Small cell lung cancer (SCLC), about 15% of cases.
Non–small cell lung cancer (NSCLC), about 85% of cases.
Diagnosis
Chest x-ray.
CT or combined PET–CT.
Cytopathology examination of pleural fluid or sputum.
Usually bronchoscopy-guided biopsy and core biopsy.
Sometimes open lung biopsy.
Treatment:
Surgery (depending on cell type and stage).
Chemotherapy :
Radiation therapy.
Immunotherapy.
36. Symptoms:
Common signs and symptoms include:
Shortness of breath: This symptom typically appears suddenly and always
gets worse with exertion.
• Chest pain: You may feel like you're having a heart attack. The pain may
become worse when you breathe deeply (pleurisy), cough, eat, bend or stoop.
The pain will get worse with exertion but won't go away when you rest.
• Cough: The cough may produce bloody or blood-streaked sputum.
Diagnosis:
• Blood tests.
• Chest X-ray.
• Ultrasound.
• Spiral CT scan.
• MRI.
Treatment:
Blood thinners (anticoagulants).
Clot dissolvers (thrombolytic).
Surgical and other procedures: Clot removal and Vein filter.